Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.
about
Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease.The fear of lymphadenopathy: A cautionary case of sarcoidosis masquerading as recurrent diffuse large b-cell lymphoma (DLBCL).
P2860
Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.
@en
type
label
Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.
@en
prefLabel
Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.
@en
P2093
P2860
P1476
Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.
@en
P2093
Clifton Mo
Mark Roschewski
S Peter Wu
Thomas Summers
P2860
P2888
P356
10.1007/S11864-016-0425-1
P577
2016-09-01T00:00:00Z
P6179
1004633355